nodes	percent_of_prediction	percent_of_DWPC	metapath
Nedocromil—asthma—atopic dermatitis	0.813	1	CtDrD
Nedocromil—FPR1—head—atopic dermatitis	0.00179	0.242	CbGeAlD
Nedocromil—PTGDR—head—atopic dermatitis	0.00169	0.228	CbGeAlD
Nedocromil—HSP90AA1—neck—atopic dermatitis	0.00153	0.208	CbGeAlD
Nedocromil—HSP90AA1—skin of body—atopic dermatitis	0.000993	0.134	CbGeAlD
Nedocromil—CYSLTR1—head—atopic dermatitis	0.000747	0.101	CbGeAlD
Nedocromil—HSP90AA1—head—atopic dermatitis	0.000648	0.0876	CbGeAlD
Nedocromil—Dermatitis—Desonide—atopic dermatitis	0.000328	0.00365	CcSEcCtD
Nedocromil—Fatigue—Diphenhydramine—atopic dermatitis	0.000328	0.00364	CcSEcCtD
Nedocromil—Fatigue—Dimenhydrinate—atopic dermatitis	0.000328	0.00364	CcSEcCtD
Nedocromil—Dyspnoea—Pimecrolimus—atopic dermatitis	0.000328	0.00364	CcSEcCtD
Nedocromil—Headache—Desonide—atopic dermatitis	0.000326	0.00363	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Pimecrolimus—atopic dermatitis	0.000318	0.00353	CcSEcCtD
Nedocromil—Dysgeusia—Fluocinolone Acetonide—atopic dermatitis	0.000316	0.00351	CcSEcCtD
Nedocromil—Pneumonia—Tacrolimus—atopic dermatitis	0.000316	0.00351	CcSEcCtD
Nedocromil—Pain—Pimecrolimus—atopic dermatitis	0.000315	0.0035	CcSEcCtD
Nedocromil—Cough—Loratadine—atopic dermatitis	0.000313	0.00348	CcSEcCtD
Nedocromil—Hypersensitivity—Fluocinonide—atopic dermatitis	0.000311	0.00345	CcSEcCtD
Nedocromil—Chest pain—Loratadine—atopic dermatitis	0.000306	0.0034	CcSEcCtD
Nedocromil—Conjunctivitis—Tacrolimus—atopic dermatitis	0.000305	0.00339	CcSEcCtD
Nedocromil—Urticaria—Diphenhydramine—atopic dermatitis	0.000302	0.00336	CcSEcCtD
Nedocromil—Urticaria—Dimenhydrinate—atopic dermatitis	0.000302	0.00336	CcSEcCtD
Nedocromil—Gastrointestinal pain—Pimecrolimus—atopic dermatitis	0.000301	0.00334	CcSEcCtD
Nedocromil—Dry mouth—Loratadine—atopic dermatitis	0.000299	0.00332	CcSEcCtD
Nedocromil—Sinusitis—Tacrolimus—atopic dermatitis	0.000294	0.00327	CcSEcCtD
Nedocromil—Anaphylactic shock—Loratadine—atopic dermatitis	0.000293	0.00326	CcSEcCtD
Nedocromil—Urticaria—Pimecrolimus—atopic dermatitis	0.000292	0.00325	CcSEcCtD
Nedocromil—Body temperature increased—Pimecrolimus—atopic dermatitis	0.000291	0.00323	CcSEcCtD
Nedocromil—Abdominal pain—Pimecrolimus—atopic dermatitis	0.000291	0.00323	CcSEcCtD
Nedocromil—Viral infection—Prednisone—atopic dermatitis	0.000288	0.0032	CcSEcCtD
Nedocromil—Gastroenteritis—Hydrocortisone—atopic dermatitis	0.000287	0.00318	CcSEcCtD
Nedocromil—Eczema—Hydrocortisone—atopic dermatitis	0.000283	0.00314	CcSEcCtD
Nedocromil—Rhinitis—Tacrolimus—atopic dermatitis	0.000282	0.00314	CcSEcCtD
Nedocromil—Cough—Fluocinolone Acetonide—atopic dermatitis	0.000282	0.00313	CcSEcCtD
Nedocromil—Pharyngitis—Tacrolimus—atopic dermatitis	0.00028	0.00311	CcSEcCtD
Nedocromil—Dizziness—Fluocinonide—atopic dermatitis	0.000279	0.0031	CcSEcCtD
Nedocromil—Asthenia—Diphenhydramine—atopic dermatitis	0.000273	0.00303	CcSEcCtD
Nedocromil—Asthenia—Dimenhydrinate—atopic dermatitis	0.000273	0.00303	CcSEcCtD
Nedocromil—Visual impairment—Tacrolimus—atopic dermatitis	0.000271	0.00302	CcSEcCtD
Nedocromil—Hypersensitivity—Pimecrolimus—atopic dermatitis	0.000271	0.00301	CcSEcCtD
Nedocromil—Cough—Mometasone—atopic dermatitis	0.000269	0.00299	CcSEcCtD
Nedocromil—Rash—Fluocinonide—atopic dermatitis	0.000266	0.00296	CcSEcCtD
Nedocromil—Dermatitis—Fluocinonide—atopic dermatitis	0.000266	0.00295	CcSEcCtD
Nedocromil—Headache—Fluocinonide—atopic dermatitis	0.000264	0.00294	CcSEcCtD
Nedocromil—Chest pain—Mometasone—atopic dermatitis	0.000262	0.00291	CcSEcCtD
Nedocromil—Diarrhoea—Dimenhydrinate—atopic dermatitis	0.00026	0.00289	CcSEcCtD
Nedocromil—Diarrhoea—Diphenhydramine—atopic dermatitis	0.00026	0.00289	CcSEcCtD
Nedocromil—Dyspepsia—Loratadine—atopic dermatitis	0.000258	0.00287	CcSEcCtD
Nedocromil—Dry mouth—Mometasone—atopic dermatitis	0.000257	0.00285	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Loratadine—atopic dermatitis	0.000253	0.00281	CcSEcCtD
Nedocromil—Fatigue—Loratadine—atopic dermatitis	0.000253	0.00281	CcSEcCtD
Nedocromil—Diarrhoea—Pimecrolimus—atopic dermatitis	0.000252	0.0028	CcSEcCtD
Nedocromil—Dizziness—Dimenhydrinate—atopic dermatitis	0.000252	0.0028	CcSEcCtD
Nedocromil—Dizziness—Diphenhydramine—atopic dermatitis	0.000252	0.0028	CcSEcCtD
Nedocromil—Anaphylactic shock—Mometasone—atopic dermatitis	0.000251	0.00279	CcSEcCtD
Nedocromil—Pain—Loratadine—atopic dermatitis	0.000251	0.00278	CcSEcCtD
Nedocromil—Vomiting—Dimenhydrinate—atopic dermatitis	0.000242	0.00269	CcSEcCtD
Nedocromil—Vomiting—Diphenhydramine—atopic dermatitis	0.000242	0.00269	CcSEcCtD
Nedocromil—Dysgeusia—Tacrolimus—atopic dermatitis	0.00024	0.00267	CcSEcCtD
Nedocromil—Rash—Dimenhydrinate—atopic dermatitis	0.00024	0.00267	CcSEcCtD
Nedocromil—Rash—Diphenhydramine—atopic dermatitis	0.00024	0.00267	CcSEcCtD
Nedocromil—Dermatitis—Dimenhydrinate—atopic dermatitis	0.00024	0.00266	CcSEcCtD
Nedocromil—Dermatitis—Diphenhydramine—atopic dermatitis	0.00024	0.00266	CcSEcCtD
Nedocromil—Gastrointestinal pain—Loratadine—atopic dermatitis	0.00024	0.00266	CcSEcCtD
Nedocromil—Headache—Dimenhydrinate—atopic dermatitis	0.000238	0.00265	CcSEcCtD
Nedocromil—Headache—Diphenhydramine—atopic dermatitis	0.000238	0.00265	CcSEcCtD
Nedocromil—Vomiting—Pimecrolimus—atopic dermatitis	0.000234	0.0026	CcSEcCtD
Nedocromil—Rash—Pimecrolimus—atopic dermatitis	0.000232	0.00258	CcSEcCtD
Nedocromil—Dermatitis—Pimecrolimus—atopic dermatitis	0.000232	0.00257	CcSEcCtD
Nedocromil—Abdominal pain—Loratadine—atopic dermatitis	0.000232	0.00257	CcSEcCtD
Nedocromil—Body temperature increased—Loratadine—atopic dermatitis	0.000232	0.00257	CcSEcCtD
Nedocromil—Headache—Pimecrolimus—atopic dermatitis	0.00023	0.00256	CcSEcCtD
Nedocromil—Tremor—Tacrolimus—atopic dermatitis	0.00023	0.00255	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.000227	0.00253	CcSEcCtD
Nedocromil—Nausea—Dimenhydrinate—atopic dermatitis	0.000226	0.00251	CcSEcCtD
Nedocromil—Nausea—Diphenhydramine—atopic dermatitis	0.000226	0.00251	CcSEcCtD
Nedocromil—Pain—Fluocinolone Acetonide—atopic dermatitis	0.000225	0.0025	CcSEcCtD
Nedocromil—Dyspnoea—Mometasone—atopic dermatitis	0.000224	0.00249	CcSEcCtD
Nedocromil—Dyspepsia—Mometasone—atopic dermatitis	0.000221	0.00246	CcSEcCtD
Nedocromil—Leukopenia—Tacrolimus—atopic dermatitis	0.00022	0.00244	CcSEcCtD
Nedocromil—Nausea—Pimecrolimus—atopic dermatitis	0.000219	0.00243	CcSEcCtD
Nedocromil—Fatigue—Mometasone—atopic dermatitis	0.000217	0.00241	CcSEcCtD
Nedocromil—Pain—Mometasone—atopic dermatitis	0.000215	0.00239	CcSEcCtD
Nedocromil—Cough—Tacrolimus—atopic dermatitis	0.000214	0.00238	CcSEcCtD
Nedocromil—Asthenia—Loratadine—atopic dermatitis	0.00021	0.00234	CcSEcCtD
Nedocromil—Chest pain—Tacrolimus—atopic dermatitis	0.000209	0.00232	CcSEcCtD
Nedocromil—Body temperature increased—Fluocinolone Acetonide—atopic dermatitis	0.000208	0.00231	CcSEcCtD
Nedocromil—Influenza—Triamcinolone—atopic dermatitis	0.000207	0.0023	CcSEcCtD
Nedocromil—Gastrointestinal pain—Mometasone—atopic dermatitis	0.000206	0.00228	CcSEcCtD
Nedocromil—Dry mouth—Tacrolimus—atopic dermatitis	0.000204	0.00227	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Hydrocortisone—atopic dermatitis	0.000204	0.00227	CcSEcCtD
Nedocromil—Diarrhoea—Loratadine—atopic dermatitis	0.0002	0.00223	CcSEcCtD
Nedocromil—Anaphylactic shock—Tacrolimus—atopic dermatitis	0.0002	0.00222	CcSEcCtD
Nedocromil—Bronchitis—Triamcinolone—atopic dermatitis	0.000199	0.00221	CcSEcCtD
Nedocromil—Abdominal pain—Mometasone—atopic dermatitis	0.000199	0.00221	CcSEcCtD
Nedocromil—Body temperature increased—Mometasone—atopic dermatitis	0.000199	0.00221	CcSEcCtD
Nedocromil—Conjunctivitis—Prednisolone—atopic dermatitis	0.000195	0.00216	CcSEcCtD
Nedocromil—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.000194	0.00216	CcSEcCtD
Nedocromil—Dizziness—Loratadine—atopic dermatitis	0.000194	0.00215	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Triamcinolone—atopic dermatitis	0.000192	0.00213	CcSEcCtD
Nedocromil—Vomiting—Loratadine—atopic dermatitis	0.000186	0.00207	CcSEcCtD
Nedocromil—Rash—Loratadine—atopic dermatitis	0.000185	0.00205	CcSEcCtD
Nedocromil—Dermatitis—Loratadine—atopic dermatitis	0.000185	0.00205	CcSEcCtD
Nedocromil—Headache—Loratadine—atopic dermatitis	0.000184	0.00204	CcSEcCtD
Nedocromil—Asthenia—Mometasone—atopic dermatitis	0.00018	0.002	CcSEcCtD
Nedocromil—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.00018	0.002	CcSEcCtD
Nedocromil—Conjunctivitis—Triamcinolone—atopic dermatitis	0.000179	0.00199	CcSEcCtD
Nedocromil—Dyspnoea—Tacrolimus—atopic dermatitis	0.000178	0.00198	CcSEcCtD
Nedocromil—Dyspepsia—Tacrolimus—atopic dermatitis	0.000176	0.00196	CcSEcCtD
Nedocromil—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000174	0.00193	CcSEcCtD
Nedocromil—Nausea—Loratadine—atopic dermatitis	0.000174	0.00193	CcSEcCtD
Nedocromil—Visual impairment—Prednisolone—atopic dermatitis	0.000173	0.00193	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000173	0.00192	CcSEcCtD
Nedocromil—Fatigue—Tacrolimus—atopic dermatitis	0.000173	0.00192	CcSEcCtD
Nedocromil—Diarrhoea—Mometasone—atopic dermatitis	0.000172	0.00191	CcSEcCtD
Nedocromil—Pain—Tacrolimus—atopic dermatitis	0.000171	0.0019	CcSEcCtD
Nedocromil—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000167	0.00186	CcSEcCtD
Nedocromil—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000166	0.00184	CcSEcCtD
Nedocromil—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000166	0.00184	CcSEcCtD
Nedocromil—Rhinitis—Triamcinolone—atopic dermatitis	0.000166	0.00184	CcSEcCtD
Nedocromil—Rhinitis—Methylprednisolone—atopic dermatitis	0.000166	0.00184	CcSEcCtD
Nedocromil—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000165	0.00183	CcSEcCtD
Nedocromil—Pharyngitis—Triamcinolone—atopic dermatitis	0.000164	0.00182	CcSEcCtD
Nedocromil—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000164	0.00182	CcSEcCtD
Nedocromil—Conjunctivitis—Betamethasone—atopic dermatitis	0.000163	0.00181	CcSEcCtD
Nedocromil—Conjunctivitis—Dexamethasone—atopic dermatitis	0.000163	0.00181	CcSEcCtD
Nedocromil—Vomiting—Mometasone—atopic dermatitis	0.00016	0.00178	CcSEcCtD
Nedocromil—Visual impairment—Methylprednisolone—atopic dermatitis	0.000159	0.00177	CcSEcCtD
Nedocromil—Urticaria—Tacrolimus—atopic dermatitis	0.000159	0.00177	CcSEcCtD
Nedocromil—Rash—Mometasone—atopic dermatitis	0.000159	0.00176	CcSEcCtD
Nedocromil—Dermatitis—Mometasone—atopic dermatitis	0.000158	0.00176	CcSEcCtD
Nedocromil—Abdominal pain—Tacrolimus—atopic dermatitis	0.000158	0.00176	CcSEcCtD
Nedocromil—Body temperature increased—Tacrolimus—atopic dermatitis	0.000158	0.00176	CcSEcCtD
Nedocromil—Headache—Mometasone—atopic dermatitis	0.000158	0.00175	CcSEcCtD
Nedocromil—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000156	0.00174	CcSEcCtD
Nedocromil—CYSLTR1—Signaling by GPCR—CCL27—atopic dermatitis	0.000151	0.00168	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—TAC1—atopic dermatitis	0.000151	0.00168	CbGpPWpGaD
Nedocromil—Nausea—Mometasone—atopic dermatitis	0.000149	0.00166	CcSEcCtD
Nedocromil—PTGDR—GPCR downstream signaling—IL5—atopic dermatitis	0.000149	0.00166	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000148	0.00165	CbGpPWpGaD
Nedocromil—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000147	0.00164	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—CCL17—atopic dermatitis	0.000147	0.00164	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—NPS—atopic dermatitis	0.000146	0.00162	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—TAC1—atopic dermatitis	0.000146	0.00162	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000145	0.00162	CbGpPWpGaD
Nedocromil—Visual impairment—Betamethasone—atopic dermatitis	0.000145	0.00161	CcSEcCtD
Nedocromil—Visual impairment—Dexamethasone—atopic dermatitis	0.000145	0.00161	CcSEcCtD
Nedocromil—CYSLTR2—Signaling Pathways—CCL22—atopic dermatitis	0.000144	0.00161	CbGpPWpGaD
Nedocromil—HSP90AA1—Corticotropin-releasing hormone—CXCL8—atopic dermatitis	0.000144	0.00161	CbGpPWpGaD
Nedocromil—Asthenia—Tacrolimus—atopic dermatitis	0.000144	0.0016	CcSEcCtD
Nedocromil—FPR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000143	0.0016	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—CXCR3—atopic dermatitis	0.000143	0.00159	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—CCR3—atopic dermatitis	0.000141	0.00157	CbGpPWpGaD
Nedocromil—Dysgeusia—Triamcinolone—atopic dermatitis	0.000141	0.00157	CcSEcCtD
Nedocromil—FPR1—Signaling by GPCR—IL5—atopic dermatitis	0.00014	0.00156	CbGpPWpGaD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—MAPK8—atopic dermatitis	0.000139	0.00155	CbGpPWpGaD
Nedocromil—PTGDR—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000139	0.00154	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000138	0.00154	CbGpPWpGaD
Nedocromil—HSP90AA1—Corticotropin-releasing hormone—IL2—atopic dermatitis	0.000138	0.00153	CbGpPWpGaD
Nedocromil—Diarrhoea—Tacrolimus—atopic dermatitis	0.000137	0.00152	CcSEcCtD
Nedocromil—CYSLTR2—GPCR ligand binding—CCR5—atopic dermatitis	0.000137	0.00153	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—KIF3A—atopic dermatitis	0.000136	0.00151	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—IL5—atopic dermatitis	0.000135	0.00151	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CCL17—atopic dermatitis	0.000135	0.00151	CbGpPWpGaD
Nedocromil—Dizziness—Tacrolimus—atopic dermatitis	0.000132	0.00147	CcSEcCtD
Nedocromil—FPR1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000132	0.00147	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—KIF3A—atopic dermatitis	0.000131	0.00146	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCL27—atopic dermatitis	0.000129	0.00143	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—CCR3—atopic dermatitis	0.000128	0.00143	CbGpPWpGaD
Nedocromil—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000128	0.00142	CcSEcCtD
Nedocromil—Vomiting—Tacrolimus—atopic dermatitis	0.000127	0.00141	CcSEcCtD
Nedocromil—PTGDR—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000127	0.00142	CbGpPWpGaD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—MAPK8—atopic dermatitis	0.000127	0.00141	CbGpPWpGaD
Nedocromil—HSP90AA1—Corticotropin-releasing hormone—MAPK8—atopic dermatitis	0.000127	0.00141	CbGpPWpGaD
Nedocromil—Rash—Tacrolimus—atopic dermatitis	0.000126	0.0014	CcSEcCtD
Nedocromil—Dermatitis—Tacrolimus—atopic dermatitis	0.000126	0.0014	CcSEcCtD
Nedocromil—CYSLTR2—GPCR downstream signaling—NPS—atopic dermatitis	0.000126	0.0014	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—TAC1—atopic dermatitis	0.000126	0.0014	CbGpPWpGaD
Nedocromil—Cough—Triamcinolone—atopic dermatitis	0.000126	0.0014	CcSEcCtD
Nedocromil—Headache—Tacrolimus—atopic dermatitis	0.000125	0.00139	CcSEcCtD
Nedocromil—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000125	0.00139	CcSEcCtD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000125	0.00139	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000123	0.00138	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CMA1—atopic dermatitis	0.000123	0.00137	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CCL11—atopic dermatitis	0.000123	0.00137	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000122	0.00136	CbGpPWpGaD
Nedocromil—Dry mouth—Triamcinolone—atopic dermatitis	0.00012	0.00133	CcSEcCtD
Nedocromil—FPR1—Signaling by GPCR—CXCL10—atopic dermatitis	0.00012	0.00133	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—FCER1A—atopic dermatitis	0.000119	0.00133	CbGpPWpGaD
Nedocromil—Nausea—Tacrolimus—atopic dermatitis	0.000119	0.00132	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—CMA1—atopic dermatitis	0.000118	0.00132	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CCL11—atopic dermatitis	0.000118	0.00132	CbGpPWpGaD
Nedocromil—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000118	0.00131	CcSEcCtD
Nedocromil—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000117	0.0013	CcSEcCtD
Nedocromil—CYSLTR2—GPCR downstream signaling—IL5—atopic dermatitis	0.000117	0.0013	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—CXCL10—atopic dermatitis	0.000115	0.00129	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—STAT6—atopic dermatitis	0.000115	0.00129	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—STAT6—atopic dermatitis	0.000115	0.00128	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCL17—atopic dermatitis	0.000115	0.00128	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—TAC1—atopic dermatitis	0.000114	0.00127	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—NPS—atopic dermatitis	0.000114	0.00127	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000113	0.00126	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CARD11—atopic dermatitis	0.000112	0.00125	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—CXCR3—atopic dermatitis	0.000112	0.00125	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—STAT6—atopic dermatitis	0.000111	0.00124	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—MS4A2—atopic dermatitis	0.000111	0.00124	CbGpPWpGaD
Nedocromil—Dyspepsia—Hydrocortisone—atopic dermatitis	0.00011	0.00122	CcSEcCtD
Nedocromil—PTGDR—GPCR downstream signaling—CCL5—atopic dermatitis	0.000109	0.00122	CbGpPWpGaD
Nedocromil—Pain—Prednisolone—atopic dermatitis	0.000109	0.00121	CcSEcCtD
Nedocromil—FPR1—GPCR ligand binding—CXCL8—atopic dermatitis	0.000109	0.00122	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CCL11—atopic dermatitis	0.000109	0.00122	CbGpPWpGaD
Nedocromil—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000109	0.00121	CbGpPWpGaD
Nedocromil—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000108	0.0012	CcSEcCtD
Nedocromil—Fatigue—Hydrocortisone—atopic dermatitis	0.000108	0.0012	CcSEcCtD
Nedocromil—CYSLTR1—Signaling Pathways—FCER2—atopic dermatitis	0.000108	0.0012	CbGpPWpGaD
Nedocromil—Pain—Hydrocortisone—atopic dermatitis	0.000107	0.00119	CcSEcCtD
Nedocromil—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000107	0.00119	CcSEcCtD
Nedocromil—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000107	0.00119	CcSEcCtD
Nedocromil—CYSLTR2—Signaling by GPCR—IL5—atopic dermatitis	0.000106	0.00118	CbGpPWpGaD
Nedocromil—PTGDR—GPCR ligand binding—CXCL8—atopic dermatitis	0.000106	0.00118	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—CCL5—atopic dermatitis	0.000105	0.00117	CbGpPWpGaD
Nedocromil—Dyspnoea—Triamcinolone—atopic dermatitis	0.000105	0.00116	CcSEcCtD
Nedocromil—Dyspepsia—Triamcinolone—atopic dermatitis	0.000103	0.00115	CcSEcCtD
Nedocromil—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000103	0.00115	CcSEcCtD
Nedocromil—FPR1—Signaling by GPCR—CCL5—atopic dermatitis	0.000103	0.00115	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—KIF3A—atopic dermatitis	0.000103	0.00115	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—CCR5—atopic dermatitis	0.000102	0.00114	CbGpPWpGaD
Nedocromil—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000102	0.00113	CcSEcCtD
Nedocromil—Urticaria—Prednisolone—atopic dermatitis	0.000102	0.00113	CcSEcCtD
Nedocromil—Fatigue—Triamcinolone—atopic dermatitis	0.000101	0.00113	CcSEcCtD
Nedocromil—Fatigue—Methylprednisolone—atopic dermatitis	0.000101	0.00112	CcSEcCtD
Nedocromil—Pain—Triamcinolone—atopic dermatitis	0.000101	0.00112	CcSEcCtD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—TNF—atopic dermatitis	0.0001	0.00112	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCL22—atopic dermatitis	0.0001	0.00111	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CCR3—atopic dermatitis	0.0001	0.00111	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—CXCL10—atopic dermatitis	9.98e-05	0.00111	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—CCL5—atopic dermatitis	9.94e-05	0.00111	CbGpPWpGaD
Nedocromil—Urticaria—Hydrocortisone—atopic dermatitis	9.92e-05	0.0011	CcSEcCtD
Nedocromil—HSP90AA1—Immune System—DEFB1—atopic dermatitis	9.89e-05	0.0011	CbGpPWpGaD
Nedocromil—Body temperature increased—Hydrocortisone—atopic dermatitis	9.87e-05	0.0011	CcSEcCtD
Nedocromil—Abdominal pain—Hydrocortisone—atopic dermatitis	9.87e-05	0.0011	CcSEcCtD
Nedocromil—PTGDR—GPCR downstream signaling—CCR5—atopic dermatitis	9.86e-05	0.0011	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—CCR3—atopic dermatitis	9.79e-05	0.00109	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CCR3—atopic dermatitis	9.66e-05	0.00108	CbGpPWpGaD
Nedocromil—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	9.59e-05	0.00107	CcSEcCtD
Nedocromil—CYSLTR1—GPCR ligand binding—CCR5—atopic dermatitis	9.49e-05	0.00106	CbGpPWpGaD
Nedocromil—Hypersensitivity—Prednisolone—atopic dermatitis	9.42e-05	0.00105	CcSEcCtD
Nedocromil—Dyspepsia—Dexamethasone—atopic dermatitis	9.39e-05	0.00104	CcSEcCtD
Nedocromil—Dyspepsia—Betamethasone—atopic dermatitis	9.39e-05	0.00104	CcSEcCtD
Nedocromil—Urticaria—Triamcinolone—atopic dermatitis	9.34e-05	0.00104	CcSEcCtD
Nedocromil—Urticaria—Methylprednisolone—atopic dermatitis	9.32e-05	0.00104	CcSEcCtD
Nedocromil—CYSLTR2—Signaling Pathways—CMA1—atopic dermatitis	9.29e-05	0.00104	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCL11—atopic dermatitis	9.29e-05	0.00104	CbGpPWpGaD
Nedocromil—Body temperature increased—Triamcinolone—atopic dermatitis	9.29e-05	0.00103	CcSEcCtD
Nedocromil—Anaphylactic shock—Prednisone—atopic dermatitis	9.29e-05	0.00103	CcSEcCtD
Nedocromil—FPR1—Signaling by GPCR—CCR5—atopic dermatitis	9.27e-05	0.00103	CbGpPWpGaD
Nedocromil—Abdominal pain—Methylprednisolone—atopic dermatitis	9.27e-05	0.00103	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	9.21e-05	0.00102	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Betamethasone—atopic dermatitis	9.21e-05	0.00102	CcSEcCtD
Nedocromil—Hypersensitivity—Hydrocortisone—atopic dermatitis	9.2e-05	0.00102	CcSEcCtD
Nedocromil—Fatigue—Betamethasone—atopic dermatitis	9.2e-05	0.00102	CcSEcCtD
Nedocromil—Fatigue—Dexamethasone—atopic dermatitis	9.2e-05	0.00102	CcSEcCtD
Nedocromil—Pain—Dexamethasone—atopic dermatitis	9.12e-05	0.00101	CcSEcCtD
Nedocromil—Pain—Betamethasone—atopic dermatitis	9.12e-05	0.00101	CcSEcCtD
Nedocromil—CYSLTR2—Signaling by GPCR—CXCL10—atopic dermatitis	9.06e-05	0.00101	CbGpPWpGaD
Nedocromil—Asthenia—Hydrocortisone—atopic dermatitis	8.96e-05	0.000995	CcSEcCtD
Nedocromil—PTGDR—Signaling by GPCR—CCR5—atopic dermatitis	8.96e-05	0.000998	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCL27—atopic dermatitis	8.91e-05	0.000993	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—NPS—atopic dermatitis	8.91e-05	0.000993	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TAC1—atopic dermatitis	8.91e-05	0.000993	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CCR3—atopic dermatitis	8.89e-05	0.000991	CbGpPWpGaD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—IL6—atopic dermatitis	8.87e-05	0.000989	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CASP1—atopic dermatitis	8.75e-05	0.000975	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—STAT6—atopic dermatitis	8.74e-05	0.000974	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CXCR3—atopic dermatitis	8.74e-05	0.000974	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—NPS—atopic dermatitis	8.73e-05	0.000972	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—TAC1—atopic dermatitis	8.73e-05	0.000972	CbGpPWpGaD
Nedocromil—Gastrointestinal pain—Betamethasone—atopic dermatitis	8.72e-05	0.000969	CcSEcCtD
Nedocromil—Gastrointestinal pain—Dexamethasone—atopic dermatitis	8.72e-05	0.000969	CcSEcCtD
Nedocromil—HSP90AA1—Disease—GLB1—atopic dermatitis	8.71e-05	0.000971	CbGpPWpGaD
Nedocromil—Hypersensitivity—Triamcinolone—atopic dermatitis	8.66e-05	0.000962	CcSEcCtD
Nedocromil—Hypersensitivity—Methylprednisolone—atopic dermatitis	8.64e-05	0.00096	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—TAC1—atopic dermatitis	8.61e-05	0.000959	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—NPS—atopic dermatitis	8.61e-05	0.000959	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—CCL5—atopic dermatitis	8.59e-05	0.000957	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—CXCR3—atopic dermatitis	8.56e-05	0.000953	CbGpPWpGaD
Nedocromil—Diarrhoea—Hydrocortisone—atopic dermatitis	8.54e-05	0.000949	CcSEcCtD
Nedocromil—Urticaria—Betamethasone—atopic dermatitis	8.47e-05	0.000942	CcSEcCtD
Nedocromil—Urticaria—Dexamethasone—atopic dermatitis	8.47e-05	0.000942	CcSEcCtD
Nedocromil—Dizziness—Prednisolone—atopic dermatitis	8.45e-05	0.000939	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—CXCR3—atopic dermatitis	8.44e-05	0.00094	CbGpPWpGaD
Nedocromil—Asthenia—Triamcinolone—atopic dermatitis	8.43e-05	0.000937	CcSEcCtD
Nedocromil—Abdominal pain—Betamethasone—atopic dermatitis	8.43e-05	0.000937	CcSEcCtD
Nedocromil—Abdominal pain—Dexamethasone—atopic dermatitis	8.43e-05	0.000937	CcSEcCtD
Nedocromil—Body temperature increased—Betamethasone—atopic dermatitis	8.43e-05	0.000937	CcSEcCtD
Nedocromil—Body temperature increased—Dexamethasone—atopic dermatitis	8.43e-05	0.000937	CcSEcCtD
Nedocromil—Asthenia—Methylprednisolone—atopic dermatitis	8.42e-05	0.000935	CcSEcCtD
Nedocromil—FPR1—Signaling Pathways—IL5—atopic dermatitis	8.28e-05	0.000923	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—CXCL8—atopic dermatitis	8.28e-05	0.000922	CbGpPWpGaD
Nedocromil—Dizziness—Hydrocortisone—atopic dermatitis	8.26e-05	0.000917	CcSEcCtD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	8.25e-05	0.000919	CbGpPWpGaD
Nedocromil—Dyspepsia—Prednisone—atopic dermatitis	8.18e-05	0.000909	CcSEcCtD
Nedocromil—CYSLTR1—GPCR downstream signaling—IL5—atopic dermatitis	8.11e-05	0.000904	CbGpPWpGaD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—IL6—atopic dermatitis	8.09e-05	0.000902	CbGpPWpGaD
Nedocromil—Rash—Prednisolone—atopic dermatitis	8.06e-05	0.000896	CcSEcCtD
Nedocromil—Dermatitis—Prednisolone—atopic dermatitis	8.05e-05	0.000895	CcSEcCtD
Nedocromil—Diarrhoea—Methylprednisolone—atopic dermatitis	8.03e-05	0.000892	CcSEcCtD
Nedocromil—Fatigue—Prednisone—atopic dermatitis	8.01e-05	0.00089	CcSEcCtD
Nedocromil—Headache—Prednisolone—atopic dermatitis	8.01e-05	0.00089	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—IL5—atopic dermatitis	8e-05	0.000891	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCL17—atopic dermatitis	7.99e-05	0.00089	CbGpPWpGaD
Nedocromil—Vomiting—Hydrocortisone—atopic dermatitis	7.94e-05	0.000882	CcSEcCtD
Nedocromil—CYSLTR1—Signaling by GPCR—NPS—atopic dermatitis	7.92e-05	0.000883	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—TAC1—atopic dermatitis	7.92e-05	0.000883	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—TLR2—atopic dermatitis	7.91e-05	0.000882	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—KIF3A—atopic dermatitis	7.91e-05	0.000881	CbGpPWpGaD
Nedocromil—Rash—Hydrocortisone—atopic dermatitis	7.87e-05	0.000875	CcSEcCtD
Nedocromil—Dermatitis—Hydrocortisone—atopic dermatitis	7.87e-05	0.000874	CcSEcCtD
Nedocromil—Headache—Hydrocortisone—atopic dermatitis	7.82e-05	0.000869	CcSEcCtD
Nedocromil—CYSLTR2—Signaling by GPCR—CCL5—atopic dermatitis	7.8e-05	0.000869	CbGpPWpGaD
Nedocromil—Dizziness—Triamcinolone—atopic dermatitis	7.77e-05	0.000864	CcSEcCtD
Nedocromil—CYSLTR1—Signaling by GPCR—CXCR3—atopic dermatitis	7.77e-05	0.000866	CbGpPWpGaD
Nedocromil—Dizziness—Methylprednisolone—atopic dermatitis	7.76e-05	0.000862	CcSEcCtD
Nedocromil—CYSLTR2—GPCR downstream signaling—CCR5—atopic dermatitis	7.74e-05	0.000862	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—FCER2—atopic dermatitis	7.72e-05	0.00086	CbGpPWpGaD
Nedocromil—Asthenia—Betamethasone—atopic dermatitis	7.65e-05	0.00085	CcSEcCtD
Nedocromil—Asthenia—Dexamethasone—atopic dermatitis	7.65e-05	0.00085	CcSEcCtD
Nedocromil—Gastrointestinal pain—Prednisone—atopic dermatitis	7.6e-05	0.000844	CcSEcCtD
Nedocromil—Nausea—Prednisolone—atopic dermatitis	7.59e-05	0.000844	CcSEcCtD
Nedocromil—CYSLTR2—Signaling Pathways—CCR3—atopic dermatitis	7.58e-05	0.000844	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	7.54e-05	0.00084	CbGpPWpGaD
Nedocromil—Vomiting—Triamcinolone—atopic dermatitis	7.47e-05	0.000831	CcSEcCtD
Nedocromil—Vomiting—Methylprednisolone—atopic dermatitis	7.46e-05	0.000829	CcSEcCtD
Nedocromil—Nausea—Hydrocortisone—atopic dermatitis	7.42e-05	0.000824	CcSEcCtD
Nedocromil—Rash—Triamcinolone—atopic dermatitis	7.41e-05	0.000824	CcSEcCtD
Nedocromil—Dermatitis—Triamcinolone—atopic dermatitis	7.41e-05	0.000823	CcSEcCtD
Nedocromil—Rash—Methylprednisolone—atopic dermatitis	7.4e-05	0.000822	CcSEcCtD
Nedocromil—Dermatitis—Methylprednisolone—atopic dermatitis	7.39e-05	0.000821	CcSEcCtD
Nedocromil—Urticaria—Prednisone—atopic dermatitis	7.38e-05	0.00082	CcSEcCtD
Nedocromil—CYSLTR1—Signaling by GPCR—IL5—atopic dermatitis	7.37e-05	0.000821	CbGpPWpGaD
Nedocromil—Headache—Triamcinolone—atopic dermatitis	7.37e-05	0.000818	CcSEcCtD
Nedocromil—Headache—Methylprednisolone—atopic dermatitis	7.35e-05	0.000816	CcSEcCtD
Nedocromil—Abdominal pain—Prednisone—atopic dermatitis	7.34e-05	0.000816	CcSEcCtD
Nedocromil—Body temperature increased—Prednisone—atopic dermatitis	7.34e-05	0.000816	CcSEcCtD
Nedocromil—Diarrhoea—Dexamethasone—atopic dermatitis	7.3e-05	0.000811	CcSEcCtD
Nedocromil—Diarrhoea—Betamethasone—atopic dermatitis	7.3e-05	0.000811	CcSEcCtD
Nedocromil—HSP90AA1—Metabolism—GLB1—atopic dermatitis	7.3e-05	0.000813	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCL22—atopic dermatitis	7.18e-05	0.0008	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—IL6—atopic dermatitis	7.17e-05	0.000799	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—KIF3A—atopic dermatitis	7.12e-05	0.000794	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CXCL10—atopic dermatitis	7.06e-05	0.000787	CbGpPWpGaD
Nedocromil—Dizziness—Dexamethasone—atopic dermatitis	7.05e-05	0.000784	CcSEcCtD
Nedocromil—Dizziness—Betamethasone—atopic dermatitis	7.05e-05	0.000784	CcSEcCtD
Nedocromil—CYSLTR2—Signaling by GPCR—CCR5—atopic dermatitis	7.03e-05	0.000783	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ADSL—atopic dermatitis	7e-05	0.000779	CbGpPWpGaD
Nedocromil—Nausea—Triamcinolone—atopic dermatitis	6.98e-05	0.000776	CcSEcCtD
Nedocromil—Nausea—Methylprednisolone—atopic dermatitis	6.97e-05	0.000774	CcSEcCtD
Nedocromil—CYSLTR1—GPCR downstream signaling—CXCL10—atopic dermatitis	6.92e-05	0.000771	CbGpPWpGaD
Nedocromil—Hypersensitivity—Prednisone—atopic dermatitis	6.84e-05	0.00076	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—CXCL10—atopic dermatitis	6.82e-05	0.00076	CbGpPWpGaD
Nedocromil—Vomiting—Dexamethasone—atopic dermatitis	6.78e-05	0.000754	CcSEcCtD
Nedocromil—Vomiting—Betamethasone—atopic dermatitis	6.78e-05	0.000754	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by VEGF—IL6—atopic dermatitis	6.77e-05	0.000754	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TAC1—atopic dermatitis	6.75e-05	0.000752	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—NPS—atopic dermatitis	6.75e-05	0.000752	CbGpPWpGaD
Nedocromil—Rash—Betamethasone—atopic dermatitis	6.73e-05	0.000747	CcSEcCtD
Nedocromil—Rash—Dexamethasone—atopic dermatitis	6.73e-05	0.000747	CcSEcCtD
Nedocromil—HSP90AA1—Immune System—STAT6—atopic dermatitis	6.72e-05	0.000749	CbGpPWpGaD
Nedocromil—Dermatitis—Betamethasone—atopic dermatitis	6.72e-05	0.000747	CcSEcCtD
Nedocromil—Dermatitis—Dexamethasone—atopic dermatitis	6.72e-05	0.000747	CcSEcCtD
Nedocromil—Headache—Dexamethasone—atopic dermatitis	6.68e-05	0.000742	CcSEcCtD
Nedocromil—Headache—Betamethasone—atopic dermatitis	6.68e-05	0.000742	CcSEcCtD
Nedocromil—Asthenia—Prednisone—atopic dermatitis	6.67e-05	0.000741	CcSEcCtD
Nedocromil—CYSLTR2—Signaling Pathways—CXCR3—atopic dermatitis	6.62e-05	0.000738	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CARD11—atopic dermatitis	6.54e-05	0.000729	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CMA1—atopic dermatitis	6.44e-05	0.000718	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCL11—atopic dermatitis	6.44e-05	0.000718	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCL27—atopic dermatitis	6.4e-05	0.000713	CbGpPWpGaD
Nedocromil—Diarrhoea—Prednisone—atopic dermatitis	6.36e-05	0.000706	CcSEcCtD
Nedocromil—Nausea—Betamethasone—atopic dermatitis	6.34e-05	0.000704	CcSEcCtD
Nedocromil—Nausea—Dexamethasone—atopic dermatitis	6.34e-05	0.000704	CcSEcCtD
Nedocromil—CYSLTR1—Signaling by GPCR—CXCL10—atopic dermatitis	6.28e-05	0.0007	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IL5—atopic dermatitis	6.28e-05	0.000699	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—CXCL8—atopic dermatitis	6.2e-05	0.000691	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—CXCL8—atopic dermatitis	6.17e-05	0.000688	CbGpPWpGaD
Nedocromil—Dizziness—Prednisone—atopic dermatitis	6.14e-05	0.000683	CcSEcCtD
Nedocromil—FPR1—Signaling Pathways—CCL5—atopic dermatitis	6.08e-05	0.000677	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—STAT6—atopic dermatitis	6.06e-05	0.000675	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—CXCL8—atopic dermatitis	5.96e-05	0.000664	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—PPARA—atopic dermatitis	5.95e-05	0.000663	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—CCL5—atopic dermatitis	5.95e-05	0.000663	CbGpPWpGaD
Nedocromil—Vomiting—Prednisone—atopic dermatitis	5.91e-05	0.000656	CcSEcCtD
Nedocromil—FPR1—GPCR downstream signaling—IL2—atopic dermatitis	5.9e-05	0.000657	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CCL5—atopic dermatitis	5.87e-05	0.000654	CbGpPWpGaD
Nedocromil—Rash—Prednisone—atopic dermatitis	5.86e-05	0.000651	CcSEcCtD
Nedocromil—Dermatitis—Prednisone—atopic dermatitis	5.85e-05	0.00065	CcSEcCtD
Nedocromil—HSP90AA1—Disease—SLC11A1—atopic dermatitis	5.84e-05	0.00065	CbGpPWpGaD
Nedocromil—Headache—Prednisone—atopic dermatitis	5.82e-05	0.000647	CcSEcCtD
Nedocromil—CYSLTR1—GPCR ligand binding—CXCL8—atopic dermatitis	5.74e-05	0.000639	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCL17—atopic dermatitis	5.74e-05	0.000639	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	5.72e-05	0.000637	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—IL2—atopic dermatitis	5.7e-05	0.000635	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—NGF—atopic dermatitis	5.63e-05	0.000627	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—CXCL8—atopic dermatitis	5.61e-05	0.000625	CbGpPWpGaD
Nedocromil—Nausea—Prednisone—atopic dermatitis	5.52e-05	0.000613	CcSEcCtD
Nedocromil—FPR1—Signaling Pathways—CCR5—atopic dermatitis	5.48e-05	0.00061	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—MAPK8—atopic dermatitis	5.45e-05	0.000608	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—NGF—atopic dermatitis	5.44e-05	0.000606	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—CXCL8—atopic dermatitis	5.41e-05	0.000603	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CCL5—atopic dermatitis	5.41e-05	0.000602	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—CCR5—atopic dermatitis	5.36e-05	0.000598	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—IL2—atopic dermatitis	5.36e-05	0.000597	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CXCL10—atopic dermatitis	5.35e-05	0.000596	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CCR5—atopic dermatitis	5.29e-05	0.000589	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCR3—atopic dermatitis	5.25e-05	0.000585	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—IL2—atopic dermatitis	5.17e-05	0.000577	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—IL6—atopic dermatitis	5.12e-05	0.000571	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—KIF3A—atopic dermatitis	5.11e-05	0.00057	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CASP1—atopic dermatitis	5.1e-05	0.000568	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CCR5—atopic dermatitis	4.87e-05	0.000543	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL5—atopic dermatitis	4.83e-05	0.000538	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—IL6—atopic dermatitis	4.71e-05	0.000525	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NPS—atopic dermatitis	4.68e-05	0.000522	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TAC1—atopic dermatitis	4.68e-05	0.000522	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—CXCL8—atopic dermatitis	4.68e-05	0.000521	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—NFKBIA—atopic dermatitis	4.65e-05	0.000518	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—NFKBIA—atopic dermatitis	4.64e-05	0.000517	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCL11—atopic dermatitis	4.62e-05	0.000515	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CMA1—atopic dermatitis	4.62e-05	0.000515	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—TLR2—atopic dermatitis	4.61e-05	0.000514	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCL5—atopic dermatitis	4.61e-05	0.000513	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CXCR3—atopic dermatitis	4.59e-05	0.000511	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—NFKBIA—atopic dermatitis	4.49e-05	0.0005	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—IL2—atopic dermatitis	4.47e-05	0.000498	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IL5—atopic dermatitis	4.35e-05	0.000485	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—STAT6—atopic dermatitis	4.35e-05	0.000484	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CD79A—atopic dermatitis	4.33e-05	0.000483	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—NGF—atopic dermatitis	4.27e-05	0.000475	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—CXCL8—atopic dermatitis	4.25e-05	0.000473	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CASP8—atopic dermatitis	4.19e-05	0.000467	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCR5—atopic dermatitis	4.15e-05	0.000463	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—IL2—atopic dermatitis	4.06e-05	0.000452	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCR3—atopic dermatitis	3.77e-05	0.00042	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CXCL10—atopic dermatitis	3.71e-05	0.000413	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL18—atopic dermatitis	3.55e-05	0.000395	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—NFKBIA—atopic dermatitis	3.52e-05	0.000392	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CD8A—atopic dermatitis	3.49e-05	0.000389	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—IL6—atopic dermatitis	3.48e-05	0.000388	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CD4—atopic dermatitis	3.44e-05	0.000384	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NPS—atopic dermatitis	3.36e-05	0.000374	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TAC1—atopic dermatitis	3.36e-05	0.000374	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CXCL8—atopic dermatitis	3.31e-05	0.000369	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CXCR3—atopic dermatitis	3.3e-05	0.000367	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—CXCL8—atopic dermatitis	3.24e-05	0.000361	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CXCL8—atopic dermatitis	3.2e-05	0.000356	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCL5—atopic dermatitis	3.19e-05	0.000356	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IL2—atopic dermatitis	3.17e-05	0.000353	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—IL6—atopic dermatitis	3.15e-05	0.000351	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IL5—atopic dermatitis	3.12e-05	0.000348	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—IL2—atopic dermatitis	3.1e-05	0.000345	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IL2—atopic dermatitis	3.06e-05	0.000341	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—IL6—atopic dermatitis	3.04e-05	0.000339	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NGF—atopic dermatitis	2.96e-05	0.00033	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—IL6—atopic dermatitis	2.96e-05	0.000329	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CCR5—atopic dermatitis	2.95e-05	0.000329	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CXCL8—atopic dermatitis	2.95e-05	0.000328	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—MAPK8—atopic dermatitis	2.92e-05	0.000325	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MAPK8—atopic dermatitis	2.91e-05	0.000325	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCR5—atopic dermatitis	2.88e-05	0.000321	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—IL2—atopic dermatitis	2.81e-05	0.000314	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MAPK8—atopic dermatitis	2.81e-05	0.000313	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—NFKBIA—atopic dermatitis	2.71e-05	0.000302	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CXCL10—atopic dermatitis	2.66e-05	0.000297	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—TNF—atopic dermatitis	2.61e-05	0.000291	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CXCL8—atopic dermatitis	2.51e-05	0.00028	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CASP8—atopic dermatitis	2.44e-05	0.000272	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NFKBIA—atopic dermatitis	2.44e-05	0.000272	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IL2—atopic dermatitis	2.4e-05	0.000267	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—IL6—atopic dermatitis	2.39e-05	0.000266	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PPARA—atopic dermatitis	2.37e-05	0.000264	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCL5—atopic dermatitis	2.29e-05	0.000255	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MAPK8—atopic dermatitis	2.21e-05	0.000246	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NGF—atopic dermatitis	2.12e-05	0.000237	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—IL6—atopic dermatitis	2.11e-05	0.000235	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IFNG—atopic dermatitis	2.08e-05	0.000231	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCR5—atopic dermatitis	2.07e-05	0.00023	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CD4—atopic dermatitis	2.01e-05	0.000224	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—IL6—atopic dermatitis	1.86e-05	0.000208	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IL6—atopic dermatitis	1.86e-05	0.000207	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL1B—atopic dermatitis	1.85e-05	0.000206	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CD4—atopic dermatitis	1.85e-05	0.000206	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL2—atopic dermatitis	1.85e-05	0.000206	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IL6—atopic dermatitis	1.8e-05	0.0002	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NFKBIA—atopic dermatitis	1.75e-05	0.000195	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CXCL8—atopic dermatitis	1.74e-05	0.000194	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—MAPK8—atopic dermatitis	1.7e-05	0.000189	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IL2—atopic dermatitis	1.66e-05	0.000185	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—IL6—atopic dermatitis	1.65e-05	0.000184	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MAPK8—atopic dermatitis	1.53e-05	0.000171	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IL6—atopic dermatitis	1.41e-05	0.000157	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CXCL8—atopic dermatitis	1.25e-05	0.000139	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IL2—atopic dermatitis	1.19e-05	0.000133	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MAPK8—atopic dermatitis	1.1e-05	0.000122	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL6—atopic dermatitis	1.08e-05	0.000121	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—IL6—atopic dermatitis	1e-05	0.000112	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IL6—atopic dermatitis	9.77e-06	0.000109	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IL6—atopic dermatitis	7.01e-06	7.82e-05	CbGpPWpGaD
